Vesícula Biliar (perezosa o extirpada)

2'-FL consistently upregulates tight junction proteins (ZO-1, Occludin, Claudin) in preclinical models of intestinal barrier dysfunction, and reduces validated markers of intestinal permeability such as diamine oxidase (DAO) and zonulin. A human randomized, double-blind, placebo-controlled trial found that 2'-FL supplementation decreased zonulin levels (a key marker of intestinal tight junction integrity) in overweight adults. It has been identified as the most potent HMO in preventing inflammation-induced rises in epithelial permeability.

Acemannan is the primary bioactive polysaccharide (beta-1,4-acemannan) from Aloe vera inner leaf gel, documented to enhance gut-barrier repair by upregulating ZO-1 tight junction proteins and promoting mucosal regeneration. A ScienceDirect study showed aloe vera glucomannan (closely related polysaccharide) maintains intestinal barrier integrity via the Nrf2-mitochondria axis. Acemannan also has documented immunomodulatory effects relevant to intestinal mucosal immune function.

Akkermansia muciniphila is a gram-negative mucolytic bacterium that inhabits the intestinal mucus layer and is consistently associated with gut barrier integrity. A 2024 PMC review (PMC11297771) specifically documents its positive effects on intestinal barrier function. Akkermansia-derived extracellular vesicles (AmEVs) were shown in PubMed-indexed research (PMID 29472701) to enhance tight junction function and reduce gut permeability in diabetic mouse models.

Aloe vera inner leaf gel contains acemannan (a polysaccharide) and other bioactive compounds that support gut-barrier repair, stimulate mucin secretion, and exert anti-inflammatory effects on the intestinal lining. A 2019 clinical study published in ScienceDirect incorporated aloe vera in a gut-relief herbal formula and found improvements in GI symptoms in Australian adults with digestive disorders. Traditional use for GI conditions spans thousands of years across multiple cultures.

Arabinogalactan is a prebiotic polysaccharide from larch tree (and other plants) that undergoes colonic fermentation to produce short-chain fatty acids and promotes growth of Bifidobacterium and Lactobacillus. It has been recognized by authoritative sources as a dietary fiber supporting gut barrier health through SCFA production and beneficial microbiota stimulation, and it modulates intestinal immune function.

Baobab fruit powder's role in intestinal barrier integrity has been highlighted in the peer-reviewed literature. A 2025 PLOS One-published double-blind RCT protocol (SANCTR/PACTR registered) specifically designates intestinal permeability as its primary outcome, using the validated urinary lactulose/mannitol ratio test in 50 adults with obesity consuming 16 g/day BFP for 45 days. Secondary biomarkers include LPS, IFABP, sCD14, and LBP. This is described as the first in vivo human study of baobab's effect on intestinal barrier function.

Berberine from barberry has been shown in preclinical models to protect and restore intestinal barrier integrity, reducing intestinal permeability ('leaky gut') through Wnt/β-catenin pathway activation and AhR pathway modulation. This mechanistic evidence supports its relevance to gut barrier health.

Perilla frutescens extract has been demonstrated to improve intestinal barrier function as measured by transepithelial electrical resistance (TEER) in a cell culture model. This intestinal barrier integrity effect is cited by Fytexia as a mechanistic pillar of Benegut's efficacy and was referenced in the 2025 clinical study publication as a proposed pathway for chronic GI benefit.

Berberine is an isoquinoline alkaloid extracted from plants such as Goldenseal, Berberis, and Coptis chinensis with documented effects on intestinal barrier integrity. Studies show berberine upregulates occludin and ZO-1 tight junction proteins in prediabetic rats, increases mucin production, and modulates gut microbiota toward beneficial species. A 2025 PMC review classified berberine as a promising adjuvant therapy for IBS, IBD, and ulcerative colitis specifically via enhancement of intestinal epithelial barrier integrity.

Beta-glucans are polysaccharide fibers found in oats, barley, and medicinal mushrooms that support intestinal barrier function through prebiotic fermentation producing SCFAs, and direct immune-modulating effects on intestinal macrophages and epithelial cells. A 2023 MDPI review of leaky gut ingredients documented that mushroom polysaccharides (primarily beta-glucans) affect SCFA production and can treat intestinal diseases including colitis and NAFLD. Beta-glucans have EFSA-confirmed health claims.

B. animalis subsp. lactis strains have demonstrated intestinal barrier-supporting activity in both preclinical models and human-relevant data. CNCM I-2494 restored gut barrier permeability in a chronic low-grade inflammation mouse model. BB-12 has been shown in vitro to increase tight junction strength and prevent epithelial barrier impairment, and HN019 maintains normal tight junction function in vitro with human clinical corroboration.

B. bifidum strain BB1 has been specifically shown to enhance intestinal epithelial tight junction (TJ) barrier function in cell models and animal studies, acting via a Toll-like receptor-2 (TLR-2) pathway. This strain protects against TNF-α-induced permeability increases, offering a mechanistic basis for therapeutic use in leaky gut and inflammatory bowel conditions. Human proof-of-concept trials are in progress.

Bifidobacterium breve is identified in authoritative systematic reviews as one of the probiotic strains with demonstrated potential for intestinal barrier support. It appeared in probiotic formulations yielding positive results in clinical and animal studies examining intestinal permeability in overweight/obese populations. It is listed among effective Bifidobacterium strains (including BR3) for barrier function.

Bifidobacterium lactis (also designated B. animalis subsp. lactis) consistently appears in systematic reviews as one of the most effective probiotic strains for reducing intestinal permeability. It has been documented to restore intestinal barrier function in IBS, obese adults, and colon cancer patients in multiple high-quality clinical studies. A systematic review (ScienceDirect, 2023) identified Bifidobacterium, including B. lactis, as among the most common effective genera in positive clinical trials.

Bifidobacterium longum is among the most studied Bifidobacterium species for intestinal barrier restoration. Multiple high-quality clinical studies demonstrate it restores intestinal barrier function and reduces intestinal permeability in IBS patients, overweight and obese adults, and colon cancer patients. A double-blind RCT in IBS patients found BB536 combined with L. rhamnosus HN001 reduced colonic permeability in subjects with elevated baseline values.

In vitro studies show Boswellia serrata extract and AKBA preserve intestinal tight-junction proteins (ZO-1, occludin), maintain transepithelial resistance, and prevent NF-κB-driven barrier disruption in colonic epithelial monolayers. This mechanism supports a role in protecting intestinal barrier integrity.

Butyrate is the primary energy source for colonocytes and upregulates tight-junction proteins (claudin-1, occludin, ZO-1) that maintain intestinal barrier integrity. Tributyrin supplementation in antibiotic-treated mice increased tight-junction protein expression and reduced inflammatory mediators. The 2025 in vitro CoreBiome tributyrin study demonstrated a protective effect on intestinal barrier function in Caco-2/THP1 co-cultures. Human RCT data specifically for tributyrin and intestinal permeability are limited.

Butyric acid is a short-chain fatty acid and primary fuel for colonocytes that directly strengthens intestinal barrier function. In human intestinal Caco-2 cells, butyrate promotes barrier function by increasing AMPK activity, accelerating tight junction assembly, and inhibiting NF-κB activation. A review in World Journal of Gastroenterology (2011) documented potential beneficial effects of butyrate in intestinal and extra-intestinal diseases including barrier restoration.

Early preclinical and in vitro evidence suggests caprylic acid and MCTs support intestinal barrier function under inflammatory conditions. Animal MCT studies show reduced intestinal permeability and increased Akkermansia abundance. Human-specific evidence is limited to indirect observations from clinical nutrition and IBD metabolomics studies.

Catechin-rich green tea extract has been shown in preclinical models to improve gut barrier integrity, reducing intestinal permeability and consequent endotoxin translocation. A clinical trial protocol was designed to test catechins' ability to alleviate gut barrier dysfunction and metabolic endotoxemia in metabolic syndrome patients.

Chicory inulin fermentation products have been shown in vitro to increase gut barrier tightness — including in compromised (leaky gut) barrier models — and animal data support reduced intestinal permeability with inulin. Human evidence is limited but mechanistically plausible through SCFA-mediated tight junction support and reduction of endotoxemia.

Evidence for citrus pectin and leaky gut is mixed. Infant clinical trials show that pectin feeding significantly improved intestinal permeability in diarrhea. Cell-line studies demonstrate pectin protects tight junction integrity. However, one large RCT in healthy adults (n=100) found no improvement in intestinal permeability with sugar beet pectin, suggesting effects may be limited to diseased or inflamed states.

Bovine colostrum contains growth factors (EGF, IGF-1), immunoglobulins, and lactoferrin that strengthen intestinal tight junctions and reduce gut permeability. A meta-analysis of 10 RCTs (Digestive Diseases and Sciences, 2024) found significant reductions in lactulose/rhamnose and lactulose/mannitol ratios after colostrum supplementation. Multiple studies in athletes show colostrum reduces exercise-induced intestinal hyperpermeability.

In vitro evidence demonstrates that Commiphora myrrh directly restores IL-13-impaired tight junction integrity in human intestinal epithelial cells, reversing claudin-2 upregulation and apoptotic barrier loss. Herbal Reality documents its use for leaky gut and IBD-related intestinal barrier dysfunction.

Berberine from Coptis chinensis preserves intestinal barrier integrity by maintaining tight junction proteins and mucus layer integrity, demonstrated in multiple animal models of colitis and metabolic syndrome. Increased Akkermansia muciniphila mediated by berberine is associated with improved gut barrier function.

Curcumin, the active polyphenol in turmeric, improves intestinal barrier function by modulating tight junction organization and reducing intestinal inflammation. A 2017 study in the American Journal of Physiology found curcumin modulated intracellular signaling and tight junction organization to improve barrier function. Multiple systematic reviews confirm anti-inflammatory GI benefits, though bioavailability is limited and tends to concentrate in the GI tract when absorbed.

DHA (docosahexaenoic acid) is an omega-3 PUFA with documented association with improved intestinal barrier integrity. In the LIBRE randomized controlled trial (PMC10468946), plasma DHA was inversely associated with fecal zonulin (a marker of intestinal permeability) in both bivariate and multivariate analyses. DHA also plays a role in maintaining and protecting tight junction structure and function as documented in intestinal epithelial cell studies.

DAO activity reflects the integrity and maturation of the small intestinal mucosa, making serum DAO a validated biomarker of increased intestinal permeability (leaky gut). Excessive histamine accumulation from DAO deficiency can disrupt tight junction proteins, worsening intestinal permeability in a bidirectional relationship.

Epigallocatechin gallate (EGCG), the major catechin in green tea, has documented effects on intestinal barrier function. A 2023 review in MDPI Molecules specifically listed EGCG among polyphenols studied for leaky gut-related diseases. EGCG reduces intestinal inflammation, modulates tight junction protein expression, and supports beneficial gut microbiota composition in multiple in vitro and animal studies.

Eicosapentaenoic acid (EPA) is an omega-3 PUFA with more potent documented effects on intestinal tight junction integrity than DHA. A Caco-2 cell study (PMC3774713) showed EPA significantly elevated occludin and ZO-1 expression and prevented tight junction distortion and redistribution induced by heat stress, while DHA was less effective. The LIBRE RCT confirmed n-3 PUFAs including EPA improve intestinal barrier integrity.

Epicatechin is a flavanol polyphenol found in cocoa, apples, and green tea that is specifically listed among polyphenols studied for leaky gut-related diseases in a 2023 peer-reviewed MDPI Molecules review. It exerts anti-inflammatory effects and supports beneficial gut microbiota that contribute to intestinal barrier maintenance. The evidence is primarily from preclinical studies and observational data.

Fish oil, rich in EPA and DHA omega-3 PUFAs, has documented effects on intestinal tight junction integrity and barrier restoration. A PMC-indexed animal study (PMC3117781) showed fish oil administration ameliorated disruption of epithelial integrity by improving tight junction morphology and function. The LIBRE RCT confirmed n-3 PUFAs improve intestinal barrier integrity, and multiple GI clinical reviews support fish oil for gut barrier health.

Fructooligosaccharides are well-researched prebiotic fibers that ferment in the colon to produce short-chain fatty acids, particularly butyrate, which nourish intestinal cells and support barrier function. Multiple authoritative sources including NIH-adjacent scientific reviews identify FOS as a key prebiotic for gut barrier support. They selectively feed beneficial bacteria (Bifidobacterium, Lactobacillus) that contribute to maintaining a healthy intestinal mucosa.

Poria cocos polysaccharides have demonstrated intestinal barrier-strengthening effects in preclinical models, upregulating tight junction protein ZO-1 in antibiotic-treated mice and preventing alcohol-induced gut leakiness. These effects are linked to reduction of intestinal inflammation and regulation of gut microbiota.

Preclinical studies show fulvic acid upregulates tight junction proteins (claudin, occludin, ZO-1) in intestinal epithelial cells, and mice on high-fat diets had improved barrier function after fulvic acid supplementation. In vitro studies confirm prevention of tight junction disassembly under inflammatory conditions.

Ginger (Zingiber officinale) has documented anti-inflammatory effects on the gastrointestinal tract through gingerol and shogaol compounds that inhibit NF-κB and COX-2 pathways. Ginger has been used in Ayurveda, TCM, and traditional European herbalism for GI conditions for thousands of years. Modern reviews of leaky gut ingredients and GI barrier support include ginger for its anti-inflammatory mucosal effects, and the 2023 MDPI leaky gut review includes ginger among herbal ingredients.

Glutamic acid (glutamate) is an amino acid and immediate metabolic precursor to glutamine, which is the primary fuel for intestinal enterocytes and a key nutrient for maintaining gut barrier function. The interconversion between glutamate and glutamine (catalyzed by glutamine synthetase) directly supports enterocyte energy metabolism and tight junction maintenance. Authoritative reviews of gut barrier nutrition consistently include glutamine-related amino acids.

Glycine is the simplest amino acid and an essential component of the intestinal epithelial repair process. It is the dominant amino acid in collagen (which constitutes the intestinal extracellular matrix) and is required for glutathione synthesis. Glycine has documented anti-inflammatory effects in intestinal epithelial cells, activating glycine-gated chloride channels that reduce NF-κB-mediated inflammatory responses. It is included in authoritative gut-healing amino acid protocols.

Glycyrrhizin is the major bioactive triterpenoid glycoside from licorice root (Glycyrrhiza glabra) with documented effects on intestinal immune function and barrier integrity. It has been shown to enhance interleukin-12 production in peritoneal macrophages, supporting mucosal immunity. Licorice root (containing glycyrrhizin compounds) is specifically listed among mucilaginous herbs that repair gut barrier function in evidence reviews, with traditional use spanning thousands of years in Ayurveda, TCM, and European herbalism.

Hemicellulose supplementation has been shown in a peer-reviewed murine study (PMC9942597, Frontiers in Microbiology, 2023) to restore gut barrier integrity by upregulating tight junction proteins (ZO-1 and occludin), reducing intestinal permeability markers (serum LPS), and attenuating systemic inflammation. These findings support a mechanistic link between hemicellulose/hemicellulase activity and intestinal barrier function. Human clinical data are not yet available.

SBI (serum-derived bovine IgG) has demonstrated significant reduction of intestinal permeability biomarkers in human clinical studies. A randomized double-blind HIV study showed SBI significantly lowered circulating zonulin and I-FABP — established markers of gut barrier disruption. Ex vivo models confirm SBI promotes gut barrier integrity more profoundly than dietary protein controls.

BSE and AKBA have been directly shown in Caco-2 intestinal epithelial cell models to prevent tight junction protein (occludin, ZO-1) disassembly induced by inflammatory stimuli, preserving intestinal barrier integrity and reducing paracellular permeability — the hallmarks of leaky gut.

Inulin is a prebiotic fiber that undergoes colonic fermentation to produce short-chain fatty acids including butyrate, which directly nourishes colonocytes and strengthens gut barrier tight junctions. It also selectively promotes growth of Bifidobacterium and Akkermansia muciniphila. Authoritative scientific reviews consistently identify inulin among the best-researched prebiotics for gut barrier support alongside FOS and galactooligosaccharides.

IMO has been shown in animal models to prevent high-fat diet-induced intestinal hyperpermeability (leaky gut phenotype) by supporting tight junction integrity and reducing circulating LPS. The mechanism involves SCFA-mediated support of the intestinal epithelial barrier. Direct human clinical trials on gut permeability endpoints are lacking.

Kefir is a fermented milk beverage containing a complex community of probiotic bacteria (Lactobacillus, Bifidobacterium, Streptococcus) and yeasts (Saccharomyces, Kluyveromyces) in a kefiran polysaccharide matrix. A study specifically found that kefir supplementation improved serum zonulin levels in overweight adults. Kefir contains Lactobacillus rhamnosus, L. acidophilus, and other strains with documented leaky gut evidence.

AG supports intestinal epithelial barrier integrity by upregulating tight-junction proteins such as occludin and ZO-1. In an RCT of HIV/AIDS patients, AG supplementation improved intestinal permeability as measured by the lactulose/mannitol ratio. Animal studies demonstrate AG protects against exercise- and inflammation-induced intestinal paracellular leakage.

L-glutamine is the primary fuel for intestinal enterocytes and is the most extensively studied amino acid for leaky gut. A 2024 systematic review and meta-analysis (Amino Acids) of randomized placebo-controlled trials found that doses above 30 g/day significantly reduced intestinal permeability markers. An RCT in post-infectious IBS patients showed normalization of the lactulose-to-mannitol (L:M) ratio after glutamine supplementation. Multiple trials in athletes and critically ill patients confirm barrier-protective effects.

L-glycine is the supplemental form of glycine, an amino acid with documented anti-inflammatory effects on intestinal epithelial cells and essential roles in glutathione synthesis and collagen/ECM production for gut lining integrity. Authoritative leaky gut ingredient reviews identify glycine-related amino acids as critical for gut healing, and glycine is included in evidence-based gut-healing amino acid protocols alongside glutamine and proline.

L-Threonine is essential for intestinal mucin synthesis and maintaining mucosal barrier integrity. Dietary threonine restriction is directly linked to increased paracellular permeability in animal models, consistent with a leaky gut phenotype. A 2011 PubMed review established threonine as a critical nutrient for mucosal integrity and barrier function. Human-specific supplementation trials for increased intestinal permeability have not been published.

Lactobacillus acidophilus is a well-characterized probiotic strain that supports intestinal barrier function through tight junction enhancement and immune modulation. A single-blind placebo-controlled RCT in IBS-D patients using a probiotic fermented milk containing L. acidophilus among other strains showed significant reduction in small bowel permeability (lactulose/mannitol ratio from 0.038 to 0.023, p<0.05). Systematic reviews consistently include L. acidophilus among strains associated with reduced intestinal permeability.

In a randomized, single-blind placebo-controlled study, a probiotic fermented milk containing L. bulgaricus significantly reduced small bowel permeability in IBS-D patients over 4 weeks. A separate pilot study using a multi-strain probiotic (including L. bulgaricus) in IBS-D patients with confirmed leaky gut found improvement in intestinal permeability in over 80% of participants after 30 days.

Lactobacillus casei is a probiotic strain consistently included in systematic reviews of probiotics that restore intestinal barrier function. It appears in multi-strain formulations that have demonstrated reduced intestinal permeability in IBS and other GI conditions. Clinical patent literature for gut permeability treatment specifically lists L. casei as an effective human-derived probiotic species.

L. gasseri SBT2055 has been shown to inhibit intestinal permeability in a high-fat diet mouse model, alongside reducing adipose tissue inflammation. The proposed mechanism involves reinforcement of tight junction proteins and reduction of endotoxemia. Human-specific leaky gut RCT data for L. gasseri are not yet available.

L. paracasei NCC2461 restored gut permeability in preclinical stress models. L. paracasei CNCM I-5220-derived postbiotic has been specifically studied for protection against leaky gut. L. paracasei HII01 significantly reduced plasma LPS (a marker of intestinal permeability) in T2DM patients in an RCT, consistent with improved barrier function.

Lactobacillus plantarum is among the most studied probiotic strains for intestinal barrier support. A systematic review and meta-analysis (Iranian Journal of Public Health, 2020) found that probiotic/synbiotic supplementation including L. plantarum reduced serum zonulin as a biomarker of intestinal permeability. L. plantarum has demonstrated ability to reinforce tight junctions and reduce permeability in IBS patients, overweight adults, and other populations across multiple RCTs.

Lactobacillus reuteri is a well-studied probiotic with documented effects on intestinal barrier function. It produces reuterin (3-hydroxypropionaldehyde), a broad-spectrum antimicrobial, and is listed among effective probiotic species in authoritative reviews for treating increased gut permeability. Systematic reviews include L. reuteri among Lactobacillus strains that restore intestinal barrier function across multiple clinical populations.

Lactobacillus rhamnosus (including the LGG strain) is one of the best-documented probiotic strains for intestinal barrier restoration. Multiple RCTs and systematic reviews demonstrate it reduces colonic permeability and serum zonulin in IBS patients. A crossover double-blind RCT in 25 IBS patients showed Bifidobacterium longum BB536 combined with L. rhamnosus HN001 reduced colonic permeability in patients with elevated baseline permeability.

Lactobacillus salivarius has been specifically studied for exercise-induced gut permeability. A study in marathon runners and triathletes found that L. salivarius LS1 (a strain native to human intestines) protected against exercise-induced leaky gut. Seed.com's scientific review specifically lists L. salivarius LS1 as having demonstrated potential in barrier support roles.

Recombinant IL-10-secreting L. lactis significantly reduced intestinal hyperpermeability (P < 0.05) in a chronic murine colitis/IBS model, with upregulation of tight junction proteins. L. lactis engineered to express SlpA showed elevated occludin and ZO-2/3 tight junction proteins in murine colitis. Even wild-type L. lactis produced a non-significant trend toward decreased permeability, suggesting an intrinsic barrier-supportive property.

Lactoferrin is an iron-binding glycoprotein present in colostrum, milk, and mucosal secretions with documented roles in intestinal barrier protection. It is found in bovine colostrum—whose meta-analysis confirmed permeability reduction—and is specifically recognized as a growth factor that reduces gastrointestinal injury. Lactoferrin strengthens tight junctions, has antimicrobial and immunomodulatory properties, and reduces intestinal inflammation.

Lion's Mane polysaccharides upregulate tight junction proteins ZO-1 and Occludin, directly strengthening the intestinal epithelial barrier. Animal studies confirm reversal of DSS-induced barrier disruption and reduced LPS translocation to the liver. Human clinical data specifically for intestinal permeability are lacking.

Luteolin reduces intestinal permeability and plasma LPS in preclinical NAFLD/NASH models, enriches beneficial gut bacteria that support barrier function, and its mitochondrial-protective effects secondarily benefit epithelial tight junction integrity.

Marshmallow root (Althaea officinalis) contains mucilaginous polysaccharides and antioxidant compounds that inhibit intestinal inflammation and support the gut mucosal barrier. In vitro studies demonstrate that marshmallow root polysaccharides and aqueous extracts stimulate cell physiology of human epithelial cells. A 2023 Caco-2 cell study showed marshmallow root in yogurt improved antioxidant activity and transepithelial electrical resistance compared to controls.

Mastic gum (from Pistacia lentiscus) is a resinous substance with documented antimicrobial effects against Helicobacter pylori and intestinal pathogens, and is traditionally used for gastrointestinal complaints in Mediterranean and Middle Eastern cultures for thousands of years. It has been listed among ingredients reported to help treat leaky gut in scientific reviews, with mechanisms including microbial balance restoration and anti-inflammatory effects on gut mucosa.

Mucin deficiency, particularly loss of MUC2, is mechanistically linked to increased intestinal permeability ('leaky gut'). Muc2 knockout mice develop intercellular junction defects and colitis, demonstrating that mucin is necessary for barrier integrity. Clinical studies in IBD patients document the co-occurrence of mucin layer abnormalities and increased gut permeability.

N-Acetyl-D-Glucosamine (NAG) is the primary precursor for glycosaminoglycans (GAGs), structural compounds that give the intestinal mucus layer its thickness, viscosity, and barrier-forming properties. It is preferentially taken up by intestinal epithelial cells and redirected toward mucin and GAG synthesis. A published ScienceDirect study listed NAG among ingredients reported to help treat leaky gut, and NAG is mechanistically distinct from glucosamine sulfate in its gut-specific applications.

Omega-3 polyunsaturated fatty acids (PUFAs), particularly EPA and DHA from fish oil, have documented effects on intestinal barrier integrity. A randomized controlled LIBRE trial (PMC10468946) showed n-3 PUFAs can improve intestinal barrier integrity, with plasma DHA inversely associated with fecal zonulin (a permeability biomarker). EPA specifically preserved tight junction protein expression (ZO-1, occludin) in heat-stressed Caco-2 intestinal cells.

Pectin fermentation promotes SCFA production that strengthens tight junction proteins and reduces intestinal permeability. Animal data show pectin reduces intestinal permeability and suppresses intestinal inflammation, with mechanistic support for a role in preventing or mitigating 'leaky gut.'

PC is a structural component of intestinal epithelial cell membranes and a key constituent of the mucus barrier that limits intestinal permeability. Depletion of mucosal PC, as seen in UC, is mechanistically linked to increased barrier dysfunction. PC's role in gut barrier support has direct biological relevance to leaky gut.

Psyllium (Plantago ovata) supplementation has been shown preclinically to restore tight junction protein expression, improve intestinal barrier integrity, and reduce intestinal permeability. These effects were demonstrated in colitis mouse models and CKD rat models. Improved gut barrier function is a key mechanism behind psyllium's broader GI benefits.

Propionate regulates tight junction protein expression—including Occludin, Claudin-1, and ZO proteins—in intestinal epithelial cells, reducing paracellular permeability. A 2023 study identified propionate as a direct regulator of tight junction barrier function via ESAM upregulation in Caco-2 cells. A 2025 RCT in IBS patients showed that increased propionate levels correlated with improved gut barrier integrity and upregulated tight junction proteins.

Psyllium (Plantago ovata) husk is a soluble dietary fiber with prebiotic properties that undergoes colonic fermentation to produce short-chain fatty acids including butyrate, which directly nourishes colonocytes and supports intestinal barrier integrity. Multiple authoritative sources identify psyllium as supporting gut barrier function through SCFA production and improved stool consistency reducing intestinal irritation. It has been used in multiple cultures for GI conditions for thousands of years.

Quercetin, a dietary flavonoid, has demonstrated ability to enhance intestinal barrier function by promoting assembly of tight junction proteins ZO-2, occludin, and claudin-1. In vitro studies in Caco-2 cell monolayers confirmed increased transepithelial electrical resistance and reduced paracellular permeability. It also stabilizes mast cells, reducing histamine-driven barrier disruption. A 2023 review in MDPI Molecules identified quercetin among the polyphenols most studied for leaky gut.

Reishi polysaccharides have been shown to strengthen intestinal tight junctions (ZO-1, occludin) in preclinical models, reducing intestinal permeability. Reishi's prebiotic activity favourably alters gut microbiota composition, indirectly reducing inflammation-driven permeability. Traditional use included gut health and stomach protection. No human RCTs specifically targeting intestinal permeability markers have been published.

Resveratrol is a stilbene polyphenol found in grapes, red wine, and Japanese knotweed with documented anti-inflammatory effects on the intestinal barrier. Multiple authoritative reviews specifically list resveratrol among polyphenols intensely studied for leaky gut-related diseases. It modulates intestinal tight junction proteins and reduces gut inflammation through SIRT1 and NF-κB pathway modulation.

Saccharomyces boulardii is a non-pathogenic probiotic yeast with substantial evidence for intestinal barrier protection. A comprehensive PMC review (PMC6375115) documents that S. boulardii CNCM I-745 restores epithelial barrier defects in IBD, infectious diarrhea, and metabolic syndrome through multiple tight junction-preserving mechanisms. The Mayo Clinic conducted a placebo-controlled parallel-group clinical trial specifically assessing its ability to counteract NSAID-induced intestinal hyperpermeability.

Poria cocos polysaccharides reinforce the intestinal mucosal barrier in preclinical models, increasing expression of tight junction proteins ZO-1, Claudin, and Occludin and reducing lipopolysaccharide leakage from gut to liver. These effects have been demonstrated in multiple animal models.

Slippery elm bark contains mucilaginous polysaccharides that coat and soothe the intestinal lining, stimulate mucus production, and assist in tightening the epithelial junctions in intestinal walls. It has been used traditionally for GI conditions since Native American times and was referenced in a 2020 ScienceDirect clinical study as assisting in tightening epithelial junctions. A 2019 published clinical formula study incorporating slippery elm showed GI symptom improvement.

A multi-ingredient clinical study including slippery elm demonstrated significant reduction of intestinal permeability (measured by lactulose-to-mannitol ratios) in Australian adults with digestive disorders over three months. In vitro and in vivo studies suggest slippery elm mucilage enhances epithelial repair. However, slippery elm has not been tested in isolation for leaky gut.

A double-blind, placebo-controlled pilot trial of S. thermophilus ST10 with tara gum in 25 healthy subjects demonstrated significant reductions in intestinal permeability markers (lactulose/mannitol ratio and sucralose) after 30 and 45 days. A separate RCT of S. thermophilus-containing fermented milk also improved small intestinal permeability in IBS patients.

THIAA administration in HFD-fed mice reduced gut permeability and increased intestinal tight junction proteins ZO-1 and occludin, protecting against diet-induced gut barrier dysfunction and metabolic endotoxemia. These are direct molecular markers of gut barrier integrity. The evidence is from a single preclinical study; human data are not yet published.

Tributyrin strengthens intestinal tight junction complexes, reducing intestinal permeability. Animal studies show it preserves tight junction proteins and reduces translocation of LPS and pathogens during inflammatory challenge. An in vitro human gut model demonstrated that tributyrin protected against inflammation-induced barrier disruption.

Curcumin strengthens intestinal barrier integrity by upregulating tight junction proteins (claudin, occludin, ZO-1) and reducing mucosal NF-κB-driven inflammation that causes gut permeability. Emerging clinical data and substantial preclinical evidence support curcumin's role in mitigating 'leaky gut.' Gut-accumulating pharmacokinetics favor local epithelial effects.

Vitamin D influences intestinal barrier function through vitamin D receptors (VDR) expressed in intestinal epithelial cells, modulating tight junction protein expression and mucosal immune signaling. A short-term RCT in Crohn's disease patients (2,000 IU/day for 3 months) showed vitamin D may improve gastroduodenal permeability. A Mayo Clinic-registered clinical trial (NCT01640496) specifically investigated vitamin D's effect on colonic permeability and tight junction protein expression in ulcerative colitis.

Vitamin D3 (cholecalciferol) is the preferred supplemental form of vitamin D with documented effects on intestinal barrier function via VDR-mediated tight junction protein upregulation. A Mayo Clinic RCT (NCT01640496) specifically studied vitamin D3's effects on colonic permeability and mucosal tight junction protein expression in ulcerative colitis. Multiple authoritative gut health reviews identify vitamin D3 as one of the top evidence-supported supplements for intestinal barrier support.

Animal studies show xylanase supplementation increases expression of intestinal tight junction proteins including ZO-1, occludin, and MUC-2, markers of epithelial barrier integrity. XOS produced by xylanase hydrolysis drive SCFA production in the colon, and SCFAs are established regulators of tight junction assembly and intestinal barrier function. No direct human clinical trials of xylanase specifically for leaky gut have been conducted.

XOS promotes gut barrier integrity by stimulating SCFA-producing bacteria that strengthen tight junction proteins (ZO-1, occludin, claudin-1). In high-fat-diet animal studies, XOS upregulated tight junction gene expression in the small intestine. The evidence is primarily preclinical with limited direct human clinical data on intestinal permeability.

A landmark 2015 randomized, double-blind, placebo-controlled trial in 52 endurance athletes showed 12 weeks of zeolite supplementation (1.85 g/day) reduced fecal zonulin concentrations by approximately 30%, normalizing levels from above the clinical cutoff. Zonulin is an established biomarker for intestinal tight-junction integrity. Animal and cell studies further corroborate a protective effect on epithelial barrier function.

Zinc supports intestinal tight junction integrity and immune function. A 2025 patient-based clinical study (PMC12429388) showed that orally administered zinc gluconate (26 mg twice daily) induced tight junctional remodeling and reduced passive transmucosal permeability in human intestinal mucosa. Zinc has a centuries-long history as a clinical treatment for diarrhea and gastrointestinal conditions, and numerous cell culture and animal model studies confirm its barrier-protective role.

Cat's claw is listed as a traditional remedy for 'leaky bowel syndrome' in multiple herbal medicine references including RxList. Its anti-inflammatory NF-κB inhibiting properties are mechanistically relevant to intestinal permeability. No human clinical trials on leaky gut specifically have been published.

Chamomile (Matricaria chamomilla / Chamaemelum nobile) has centuries of traditional use for gastrointestinal inflammatory conditions in European, Middle Eastern, and South American folk medicine. Its bioactive apigenin and bisabolol compounds have documented anti-inflammatory and spasmolytic effects on the GI mucosa. The German Commission E has approved chamomile for GI spasms and inflammatory GI conditions, supporting its traditional gut mucosal protective use.

Collagen supplementation—particularly in the form of hydrolyzed collagen peptides—has been used traditionally (particularly as bone broth) for gut lining support and is increasingly studied for intestinal barrier support. Collagen provides glycine, proline, and hydroxyproline—amino acids critical for intestinal epithelial cell integrity and repair. Traditional use spans multiple cultures as a gut-healing food (bone broth), and modern functional medicine promotes it for leaky gut.

Glucosamine is an amino monosaccharide and substrate for glycosaminoglycan synthesis, which is essential for the intestinal mucus layer. N-acetylglucosamine (NAG) is the acetylated form with more direct evidence for gut barrier support; glucosamine sulfate provides raw material for GAG synthesis that constitutes the mucus barrier. Traditional and functional medicine use of glucosamine for GI mucosal support is based on its structural role in proteoglycan synthesis.

L-Proline is an amino acid essential for collagen synthesis and thus for maintaining the structural integrity of the intestinal extracellular matrix and lamina propria. It is a constituent of the collagen-rich connective tissue that supports the intestinal epithelium. Traditional use includes collagen-rich foods (bone broth, gelatin) for gut healing, and proline is a key amino acid in collagen protein that supports mucosal structural integrity.

Peppermint (Mentha × piperita) has documented clinical evidence for reducing GI symptoms in IBS through enteric-coated peppermint oil capsules, which reduce intestinal spasm and mucosal irritation. It was specifically included in a published clinical gut-relief formula (ScienceDirect 2019) tested in adults with digestive disorders. Commission E and ESCOP monographs support peppermint oil for functional GI disorders. Its menthol blocks TRPM8 channels and reduces intestinal inflammation.

Triphala is a classical Ayurvedic herbal formula composed of three fruits (Amalaki/Emblica officinalis, Bibhitaki/Terminalia bellirica, Haritaki/Terminalia chebula) with extensive traditional use for GI conditions. It contains ellagic acid, gallic acid, and chebulinic acid with documented antioxidant and anti-inflammatory properties. Modern research suggests it supports gut microbiome health and mucosal integrity, and it is used in Ayurveda specifically to tonify and strengthen the GI mucosa.